Biotech group Chi-Med plans Hong Kong listing of up to $500 mln - sources

Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close to the matter said could raise up to $500 million.

from Reuters: New Issues News https://reut.rs/2XhKzW1